Cyclacel Pharmaceuticals, Inc. Contracts & Agreements

Form of Series C Warrant (Filed With SEC on November 15, 2024)

Form of Series D Warrant (Filed With SEC on November 15, 2024)

Form of Placement Agent Warrant (Filed With SEC on November 15, 2024)

Warrant Exercise and Reload Agreement, dated November 13, 2024 (Filed With SEC on November 15, 2024)

Cyclacel Pharmaceuticals, Inc. Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on June 25, 2024)

Form of Pre-Funded Warrant (Filed With SEC on May 2, 2024)

Form of Series A Warrant (Filed With SEC on May 2, 2024)

Form of Series B Warrant (Filed With SEC on May 2, 2024)

Form of Placement Agent Warrant (Filed With SEC on May 2, 2024)

Securities Purchase Agreement, dated as of April 30, 2024, between the Company and the purchaser named therein (Filed With SEC on May 2, 2024)

Form of Registration Rights Agreement, dated as of April 30, 2024, between the Company and the purchaser named therein (Filed With SEC on May 2, 2024)

Form of Placement Agency Agreement (Filed With SEC on April 19, 2024)

Form of Common Warrant (Filed With SEC on April 19, 2024)

Form of Pre-Funded Warrant (Filed With SEC on April 19, 2024)

Form of Securities Purchase Agreement (Filed With SEC on April 19, 2024)

Form of Warrant Agency Agreement (Filed With SEC on April 19, 2024)

Description of Securities (Filed With SEC on March 21, 2024)

Consulting Agreement by and between Cyclacel Pharmaceuticals, Inc. and Brian Schwartz, M.D., dated January 26, 2024 (Filed With SEC on March 21, 2024)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on December 26, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on December 26, 2023)

Placement Agency Agreement by and between the Company and Ladenburg Thalmann & Co. Inc., dated December 21, 2023 (Filed With SEC on December 26, 2023)

Securities Purchase Agreement, dated December 21, 2023, by and among the Company and the Purchasers (Filed With SEC on December 26, 2023)

Securities Purchase Agreement, dated December 21, 2023, by and among the Company and Spiro Rombotis and Paul McBarron (Filed With SEC on December 26, 2023)

Cyclacel Pharmaceuticals, Inc. Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on June 14, 2023)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis (Filed With SEC on May 4, 2023)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron (Filed With SEC on May 4, 2023)

Description of Securities (Filed With SEC on March 8, 2023)

Form of Indemnification Agreement for directors (Filed With SEC on March 8, 2023)

Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis, effective as of January 1, 2023 (Filed With SEC on December 30, 2022)

Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron, effective as of January 1, 2023 (Filed With SEC on December 30, 2022)

Cyclacel Pharmaceuticals, Inc. Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on June 16, 2022)

Description of Securities (Filed With SEC on March 30, 2022)

Controlled Equity Offering Sales Agreement, dated as of August 12, 2021, by and among Cyclacel Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 12, 2021)

Executed Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis (Filed With SEC on July 12, 2021)

Executed Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron (Filed With SEC on July 12, 2021)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis (Filed With SEC on June 17, 2021)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron (Filed With SEC on June 17, 2021)

Underwriting Agreement, dated March 12, 2021, by and between Cyclacel Pharmaceuticals, Inc. and Oppenheimer & Co. Inc (Filed With SEC on March 15, 2021)

Description of Securities (Filed With SEC on March 1, 2021)

Form of Retirement Agreement, by and between Cyclacel Pharmaceuticals, Inc. and Judy H. Chiao, MD (Filed With SEC on February 24, 2021)

Employment Extension Agreement by and between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis, dated as of January 14, 2021 (Filed With SEC on January 15, 2021)

Employment Extension Agreement by and between Cyclacel Pharmaceuticals, Inc. and Paul McBarron, dated as of January 14, 2021 (Filed With SEC on January 15, 2021)

Form of Warrant (Filed With SEC on December 22, 2020)

Form of Securities Purchase Agreement (Filed With SEC on December 22, 2020)

Cyclacel Pharmaceuticals, Inc. 2020 Inducement Equity Incentive Plan (Filed With SEC on November 12, 2020)

Form of Stock Option Grant Notice and Stock Option Agreement under the Cyclacel Pharmaceuticals, Inc. 2020 Inducement Equity Incentive Plan (Filed With SEC on November 12, 2020)

Co-Placement Agency Agreement, by and among Cyclacel Pharmaceuticals, Inc., Roth Capital Partners, LLC, Ladenburg Thalmann & Co. Inc., and Brookline Capital Markets, a division of... (Filed With SEC on April 24, 2020)

Securities Purchase Agreement, by and among Cyclacel Pharmaceuticals, Inc. and the purchasers identified on the signature pages thereto, dated as of April 21, 2020 (Filed With SEC on April 24, 2020)

Form of Pre-Funded Warrant (Filed With SEC on April 24, 2020)

Form of Common Warrant (Filed With SEC on April 24, 2020)

Form of Co-Placement Agency Agreement (Filed With SEC on April 14, 2020)

Form of Pre-Funded Warrant (Filed With SEC on April 14, 2020)

Form of Warrant (Filed With SEC on April 14, 2020)

Form of Securities Purchase Agreement (Filed With SEC on April 14, 2020)

Form of Warrant to purchase shares of Cyclacel Pharmaceuticals, Inc.s Common Stock (previously filed as Exhibit 4.3 to the Registrants Registration Statement on Form S-1 (No.... (Filed With SEC on March 5, 2020)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis (Filed With SEC on January 7, 2019)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron (Filed With SEC on January 7, 2019)

Clinical Collaboration Agreement, dated October 1, 2018, by and between Cyclacel Pharamceuticals, Inc. and The University of Texas MD Anderson Cancer Center (Filed With SEC on November 13, 2018)

Common Stock Sales Agreement, dated October 4, 2018, by and between Cyclacel Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 4, 2018)

Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 1, 2018)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis (Filed With SEC on December 12, 2017)

Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron (Filed With SEC on December 12, 2017)

CYCLACEL PHARMACEUTICALS, INC. 2015 EQUITY INCENTIVE PLAN Effective May 22, 2015 Revised May 30, 2017 (Filed With SEC on August 10, 2017)

2,164,000 SHARES ofCommon Stock, 8,872 SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO 4,436,000 SHARES OF COMMON STOCK) AND 6,600,000Warrants (exercisable for... (Filed With SEC on July 21, 2017)

_________ SHARES ofCommon Stock, _______ SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO ____ SHARES OF COMMON STOCK) AND __________Warrants (exercisable for ____... (Filed With SEC on July 17, 2017)

COMMON STOCK PURCHASE WARRANT cyclacelpharmaceuticals, inc. (Filed With SEC on July 17, 2017)

_________ SHARES ofCommon Stock, _______ SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO ____ SHARES OF COMMON STOCK) AND __________Warrants (exercisable for ____... (Filed With SEC on June 30, 2017)

[Form of Preferred Stock Certificate] (Filed With SEC on June 30, 2017)

COMMON STOCK PURCHASE WARRANT cyclacelpharmaceuticals, inc. (Filed With SEC on June 30, 2017)

CYCLACEL PHARMACEUTICALS, INC. 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 June 27, 2017 (Filed With SEC on June 27, 2017)

CYCLACEL PHARMACEUTICALS, INC. 200 Connell Drive, Suite 1500 Berkeley Heights, NJ 07922 December 22, 2016 (Filed With SEC on March 31, 2017)

Cyclacel Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 23, 2016)

Cyclacel Pharmaceuticals,Inc. Up to $8,350,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on July 13, 2015)

CYCLACEL PHARMACEUTICALS, INC. 2015 EQUITY INCENTIVE PLAN (Filed With SEC on May 22, 2015)

430 Park Avenue | New York,New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC (Filed With SEC on March 4, 2015)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 4, 2015)

2,857,143 Shares CYCLACEL PHARMACEUTICALS INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 4, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on March 26, 2014)

EMPLOYMENTAGREEMENT (Filed With SEC on March 26, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 14, 2013)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 14, 2013)

CYCLACEL PHARMACEUTICALS, INC. (a Delaware corporation) 6,666,667 Shares UNDERWRITING AGREEMENT (Filed With SEC on May 16, 2013)

CYCLACEL PHARMACEUTICALS, INC. SECURITIES EXCHANGE AGREEMENT DECEMBER 31, 2012 (Filed With SEC on May 13, 2013)

CYCLACEL PHARMACEUTICALS, INC. SECURITIES EXCHANGE AGREEMENT MARCH 27, 2012 (Filed With SEC on May 13, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 17, 2012)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 17, 2012)

CYCLACEL PHARMACEUTICALS, INC. AMENDED AND RESTATED 2006 EQUITY INCENTIVE PLAN Effective March 16, 2006 Revised May 21, 2007 Amended and Restated May 14, 2008 Revised May 23, 2012 (Filed With SEC on May 24, 2012)

PURCHASE AGREEMENT (Filed With SEC on May 15, 2012)

EX-101 INSTANCE DOCUMENT (Filed With SEC on August 12, 2011)

CYCLACEL PHARMACEUTICALS, INC. (a Delaware corporation) 7,617,646 Units UNDERWRITING AGREEMENT (Filed With SEC on July 1, 2011)

CYCLACEL PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK To Purchase _________ Shares of Common Stock (Filed With SEC on July 1, 2011)

consolidated balance sheets as of March 31, 2009, June 30, 2009, September 30, 2009, December 31, 2009, March 31, 2010, June 30, 2010, and September 30, 2010 and statement of... (Filed With SEC on March 31, 2011)

CHANGE IN CONTROL AGREEMENT (Filed With SEC on December 14, 2010)

CYCLACEL PHARMACEUTICALS, INC. Warrant To Purchase Common Stock (Filed With SEC on October 5, 2010)

PURCHASE AGREEMENT (Filed With SEC on October 5, 2010)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 5, 2010)

2,350,000 Units CYCLACEL PHARMACEUTICALS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on January 21, 2010)

CYCLACEL PHARMACEUTICALS, INC. Warrant To Purchase Common Stock (Filed With SEC on January 21, 2010)

FORM OF SUBSCRIPTION AGREEMENT (Filed With SEC on January 21, 2010)

2,850,000 Units (Filed With SEC on January 11, 2010)

CYCLACEL PHARMACEUTICALS, INC. Warrant To Purchase Common Stock (Filed With SEC on January 11, 2010)

FORM OF SUBSCRIPTION AGREEMENT (Filed With SEC on January 11, 2010)

AMENDED AND RESTATED WARRANT (Filed With SEC on November 25, 2009)

AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 25, 2009)

Financial Statements (Filed With SEC on August 13, 2009)

4,000,000 Units (Filed With SEC on July 24, 2009)

CYCLACEL PHARMACEUTICALS, INC. (Filed With SEC on July 24, 2009)

FORM OF SUBSCRIPTION AGREEMENT (Filed With SEC on July 24, 2009)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT OF SPIRO ROMBOTIS (Filed With SEC on May 15, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on April 2, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on March 24, 2008)

WARRANT (Filed With SEC on December 11, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 11, 2007)

COMMON STOCK PURCHASE AGREEMENT by and between KINGSBRIDGE CAPITAL LIMITED and CYCLACEL PHARMACEUTICALS, INC. dated as of December 10, 2007 (Filed With SEC on December 11, 2007)

ASSET PURCHASE AGREEMENT BY AND AMONG ALIGN PHARMACEUTICALS, LLC ALIGN HOLDINGS, LLC, as Seller, and ACHILLES ACQUISITION, LLC, as Buyer Dated as of October 5, 2007 (Filed With SEC on November 7, 2007)

200 Connell Drive, #1600, Berkeley Heights, New Jersey, 07922, USA Tel -1 ###-###-#### Fax -1 ###-###-#### (Filed With SEC on November 7, 2007)

Cyclacel Pharmaceuticals, INC. DATED JANUARY 19, 2006 2006 EQUITY INCENTIVE PLAN Effective March 16, 2006 (Filed With SEC on June 19, 2007)

SUBSCRIPTIONAGREEMENT (Filed With SEC on February 15, 2007)

CYCLACELPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMONSTOCK To Purchase [ ]Shares of Common Stock (Filed With SEC on February 15, 2007)

4,249,668Units CYCLACEL PHARMACEUTICALS,INC. PLACEMENT AGENTAGREEMENT (Filed With SEC on February 15, 2007)

DATED , 2006 (Filed With SEC on March 22, 2006)

STOCK PURCHASE AGREEMENT between: XCYTE THERAPIES, INC., a Delaware corporation; (Filed With SEC on December 20, 2005)

ASSET PURCHASE AGREEMENT (Filed With SEC on December 20, 2005)

FIFTH AMENDMENT TO LEASE (Filed With SEC on December 2, 2005)

- 2 - (Filed With SEC on October 11, 2005)

AGREEMENT (Filed With SEC on October 11, 2005)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on August 15, 2005)

XCYTE THERAPIES, INC. RETENTION AND SEPARATION AGREEMENT (Filed With SEC on August 15, 2005)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 15, 2005)

XCYTE THERAPIES, INC. (Filed With SEC on June 21, 2005)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on May 18, 2005)

SUPPLY AGREEMENT (Filed With SEC on May 16, 2005)

XCYTE THERAPIES, INC. (Filed With SEC on November 15, 2004)

XCYTE THERAPIES, INC. 1,500,000 Shares (Filed With SEC on October 21, 2004)

INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on October 21, 2004)

XCYTE THERAPIES, INC. (Filed With SEC on October 21, 2004)

AMENDMENT NO. 7 (Filed With SEC on October 8, 2004)

AMENDMENT NO. 5 (Filed With SEC on October 8, 2004)

MASTER SECURITY AGREEMENT (Filed With SEC on October 7, 2004)

AMENDMENT (Filed With SEC on October 7, 2004)

AMENDMENT NO. 2 (Filed With SEC on October 7, 2004)

XCYTE THERAPIES, INC. (Filed With SEC on October 7, 2004)

AMENDMENT NO. 6 (Filed With SEC on October 7, 2004)

AMENDMENT NO. 4 (Filed With SEC on October 7, 2004)

[XCYTE THERAPIES, INC. COMPANY LETTERHEAD] June 14, 2004 (Filed With SEC on August 16, 2004)

(RESEARCH BEADS) (Filed With SEC on May 17, 2004)

XCYTE THERAPIES, INC. (Filed With SEC on May 17, 2004)

XCYTE THERAPIES, INC. (Filed With SEC on March 16, 2004)

XCYTE THERAPIES, INC. (Filed With SEC on March 9, 2004)

COLLABORATION AGREEMENT (Filed With SEC on March 9, 2004)

XCYTE THERAPIES,INC. Series F Preferred Stock Purchase Warrant (Filed With SEC on March 3, 2004)

COLLABORATION AGREEMENT (Filed With SEC on March 3, 2004)

XCYTE THERAPIES, INC. Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on February 17, 2004)

INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on February 17, 2004)

XCYTE THERAPIES,INC. Series F Preferred Stock Purchase Warrant (Filed With SEC on February 17, 2004)

THIRD AMENDMENT TO LEASE (Filed With SEC on February 17, 2004)

LICENSE AND SUPPLY AGREEMENT (Filed With SEC on February 17, 2004)

XCYTE (Filed With SEC on February 17, 2004)

SECTION 1: DEFINITIONS OF TERMS (Filed With SEC on February 17, 2004)

LICENSE AGREEMENT (Filed With SEC on February 17, 2004)

AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on February 17, 2004)

NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 17, 2004)

AGREEMENT (Filed With SEC on February 17, 2004)

COLLABORATION AGREEMENT (Filed With SEC on February 17, 2004)

XCYTE THERAPIES, INC. (Filed With SEC on February 17, 2004)

XCYTE THERAPIES, INC. (Filed With SEC on November 21, 2003)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 21, 2003)

WAIVER OF PREEMPTIVE RIGHTS AND AMENDMENT OF AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on November 21, 2003)

XCYTE THERAPIES,INC. Preferred Stock Purchase Warrant (Filed With SEC on November 21, 2003)

CONFIDENTIAL (Filed With SEC on November 21, 2003)

AMENDMENT NO. 1 TO LETTER OF INTENT (Filed With SEC on November 21, 2003)

AMENDMENT NO. 2 TO LETTER OF INTENT (Filed With SEC on November 21, 2003)

LICENSE AND SUPPLY AGREEMENT (Filed With SEC on November 21, 2003)

SECTION 1: DEFINITIONS OF TERMS (Filed With SEC on November 21, 2003)

XCYTE THERAPIES, INC. Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on October 10, 2003)

INDEMNIFICATION AGREEMENT (Filed With SEC on October 10, 2003)

XCYTE THERAPIES, INC. (Filed With SEC on October 10, 2003)

XCYTE THERAPIES, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on October 10, 2003)

CONSENT TO AMENDMENT (Filed With SEC on October 10, 2003)

XCYTE THERAPIES,INC. Common Stock Purchase Warrant (Filed With SEC on October 10, 2003)

XCYTE THERAPIES,INC. Series E Preferred Stock Purchase Warrant (Filed With SEC on October 10, 2003)

XCYTE THERAPIES,INC. Common Stock Purchase Warrant (Filed With SEC on October 10, 2003)

MASTER SECURITY AGREEMENT No. 3081030 Dated as of July 1, 2003 (Agreement) (Filed With SEC on October 10, 2003)

XCYTE THERAPIES,INC. Series F Preferred Stock Purchase Warrant (Filed With SEC on October 10, 2003)

SENIOR LOAN AND SECURITY AGREEMENT NO. 6261 (Filed With SEC on October 10, 2003)

MASTER SECURITY AGREEMENT (Filed With SEC on October 10, 2003)

LEASE AGREEMENT (Filed With SEC on October 10, 2003)

FIRST AMENDMENT TO LEASE (Filed With SEC on October 10, 2003)

SECOND AMENDMENT TO LEASE (Filed With SEC on October 10, 2003)

LEASE (Filed With SEC on October 10, 2003)

XCYTE THERAPIES, INC. (Filed With SEC on October 10, 2003)

LICENSE AGREEMENT (Filed With SEC on October 10, 2003)

NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on October 10, 2003)

AGREEMENT (Filed With SEC on October 10, 2003)

AMENDMENT NO. 1 (Filed With SEC on October 10, 2003)

AMENDMENT NO. 2 (Filed With SEC on October 10, 2003)

AMENDMENT NO. 3 (Filed With SEC on October 10, 2003)

AMENDMENT NO. 4 (Filed With SEC on October 10, 2003)

AMENDMENT NO. 5 (Filed With SEC on October 10, 2003)

AGREEMENT (Filed With SEC on October 10, 2003)

AMENDMENT NO. 2 (Filed With SEC on October 10, 2003)

AMENDMENT NO. 3 (Filed With SEC on October 10, 2003)

XCYTE THERAPIES, INC. (Filed With SEC on October 10, 2003)

Category

Industry

Companies

Contracts

Cyclacel Pharmaceuticals, Inc. Contracts & Agreements